Stay updated with breaking news from Chaime Orlev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Largest Commercial Agreement in Kamada’s History Becomes Effective in January 2024 and Includes $180 Million of Revenues to Kamada Over the First Four Years of the Eight Year TermFinancial Terms...
Kamada Provides Corporate Update on its Israel Operations Rehovot, Israel, and Hoboken, NJ - October 10, 2023 -- Kamada Ltd. , a commercial stage global biopharmaceutical...
The Extended Agreement Term is Until March 2026The Company Generated Approximately $16 Million in Revenue from Sales of KEDRAB to Kedrion in 2022 and Anticipates a Significant Increase in 2023 ...
Operator: Greetings and welcome to the Kamada Ltd. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Total Revenues for First Quarter of 2023 were $30.7 Million, Up 9% Year-over-YearFirst Quarter 2023 EBITDA of $3.8 Million, Increase of 16% Year-over-YearSolid First Quarter Results and Expected... | May 24, 2023